MedPath

CARBON MONOX, HELIUM, OXYGEN, NITROGEN L.D.M.

CARBON MONOX, HELIUM, OXYGEN, NITROGEN L.D.M.

Approved
DIN Number

02014424

Drug Class

Human

Market Date

Dec 31, 1993

Company
HC

Praxair Canada Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02014424
AIG Number0415738002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V03AN MEDICAL GASES
Product Specifications
Dosage FormGas
Route of AdministrationInhalation
AHFS Classification92:92.00
Health Canada Classification

ACTIVE INGREDIENTS (4)

CARBON MONOXIDEActive
Strength: 0.3 %
Monograph: CARBON MONOXIDE
HELIUMActive
Strength: 10.5 %
Monograph: HELIUM
NITROGENActive
Strength: 67.7 %
Monograph: NITROGEN
OXYGENActive
Strength: 21.5 %
Monograph: OXYGEN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.